Near-Term Approval Expected for Three New Combination Medications in Hepatitis C
Recent drug approvals and continuing breakthroughs in research are creating additional treatment options for patients with hepatitis C.
Updated Guidelines Help Prioritize Treatments in Hepatitis C
Treatment for hepatitis C should be offered to the sickest patients first, according to updated guidelines from the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases.
Strategies for Slowing the Progression of Liver Fibrosis in Hepatitis C
In 2 recent studies, statins and aspirin have been associated with lower rates of progression of liver fibrosis in patients with hepatitis C.
Hepatitis C on Track to Become a Rare Disease by 2036
Screening of newborn children for hepatitis C and new, more effective hepatitis C treatments may virtually eliminate the disease in the United States by 2036, according to some liver disease experts.
2 Commerce Drive Cranbury, NJ 08512